Dr Drew Brockman is a Postdoctoral Research Fellow at the Centre for Integrated Preclinical Drug Development (CIPDD), Faculty of Medicine and Biomedical Sciences at The University of Queensland. Dr Brockman received his graduate training from the University of Minnesota in Nutritional Science. His research interests include profiling and new drug development in the pain field as well as dietary influences on diabetes and obesity, particularly the effects of dietary fibre.
His past research focused on metabolic changes in the liver during the development of type 2 diabetes and hepatic steatosis using dietary interventions that alter the environment of the intestinal tract. He also studied the viscosity and fermentability properties of dietary fibers and their effect on the gene expression, adiposity-related and inflammatory peptides and fuel oxidation patterns. He has now transitioned from nutrition to the field of pharmacological treatment of pain-related behaviour for his current postdoctoral position and has been able to apply his strong biochemistry background to current work and projects such as identifying molecular mechanisms of experimental treatments in pain relief and the pharmacodynamics of test compounds on molecular targets.